Skip to main content

IQVIA Holdings, Inc. (IQV) Stock Analysis

SellVALUE-TRAP 1/5Moderate Confidence

Healthcare · Diagnostics & Research

Earnings in 5 days (2026-05-05). Expect elevated volatility around the report — consider waiting for post-earnings price action before new entries.

Sell if holding. Momentum 1.5/10 is below the 5.0 floor at $158.44 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Leverage penalty (D/E 2.5): -1.5; Earnings in 5 days (event risk).

IQVIA is a global provider of clinical research services, commercial insights, and healthcare intelligence with approximately 93,000 employees across 100+ countries. Revenue is generated through Research & Development Solutions (CRO), Technology & Analytics Solutions (healthcare... Read more

$158.44+31.6% A.UpsideScore 5.7/10#2 of 25 Diagnostics & Research
Stop $149.87Target $208.44(analyst − 10%)A.R:R 3.9:1
Analyst target$231.60+46.2%20 analysts
$208.44our TP
$158.44price
$231.60mean
$287

Sell if holding. Momentum 1.5/10 is below the 5.0 floor at $158.44 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Leverage penalty (D/E 2.5): -1.5; Earnings in 5 days (event risk). Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Score 5.7/10, moderate confidence.

Passes 5/7 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags, news events none recent, semi cycle peak clear). Fails on weak momentum and earnings proximity 5d<=7d. Suitability: aggressive.

Thesis

Rewards
Strong earnings beat streak (4/4)
Attractive valuation
Analyst upside: 32%
Risks
Leverage penalty (D/E 2.5): -1.5
Earnings in 5 days (event risk)
Negative momentum

Key Metrics

P/E (TTM)20.0
P/E (Fwd)11.1
Mkt Cap$26.3B
EV/EBITDA13.9
Profit Mgn8.3%
ROE21.4%
Rev Growth10.3%
Beta1.39
DividendNone
Rating analysts31

Quality Signals

Piotroski F7/9

Options Flow

P/C1.21bearish
IV67%elevated
Max Pain$320+102.0% vs spot

Material Events(8-K, last 90d)

  • 2026-04-23Item 5.02LOW
    2026 Annual Meeting: stockholders approved the 2026 Incentive and Stock Award Plan replacing the 2017 plan. Routine compensatory arrangement authorizing stock options, restricted stock units, and performance-based awards.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer

Rating Breakdown

1 floor-breaker

Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static

Macd
0.0
Volume
0.0
Obv
1.0
Ma Position
2.2
Rsi
4.5
Volume distribution (falling OBV)Below 200-MA but MA still rising (+0.9%/30d) — pullback in uptrend, not confirmed weakness
GatesMomentum 1.5<4.5EARNINGS PROXIMITY 5d<=7dA.R:R 3.9 ≥ 1.5Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTSEMI CYCLE PEAK CLEARSuitability: Aggressive
RSI
41 · Neutral
20D MA 50D MA 200D MADEATH CROSSSupport $154.50Resistance $180.98

Price Targets

$150
$208
A.Upside+31.6%
A.R:R3.9:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeCautious

Risk Alerts

! Momentum score 1.5/10 — below 4.5 minimum
! EARNINGS_PROXIMITY:5d<=7d

Earnings

B
B
B
B
4/4 beats
Next Earnings2026-05-05 (5d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is IQV stock a buy right now?

Sell if holding. Momentum 1.5/10 is below the 5.0 floor at $158.44 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Leverage penalty (D/E 2.5): -1.5; Earnings in 5 days (event risk). Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Prior stop was $149.87. Score 5.7/10, moderate confidence.

What is the IQV stock price target?

Take-profit target: $208.44 (+31.6% upside). Prior stop was $149.87. Stop-loss: $149.87.

What are the risks of investing in IQV?

Leverage penalty (D/E 2.5): -1.5; Earnings in 5 days (event risk); Negative momentum.

Is IQV overvalued or undervalued?

IQVIA Holdings, Inc. trades at a P/E of 20.0 (forward 11.1). TrendMatrix value score: 8.0/10. Verdict: Sell.

What do analysts say about IQV?

31 analysts cover IQV with a consensus score of 4.2/5. Average price target: $232.

What does IQVIA Holdings, Inc. do?IQVIA is a global provider of clinical research services, commercial insights, and healthcare intelligence with...

IQVIA is a global provider of clinical research services, commercial insights, and healthcare intelligence with approximately 93,000 employees across 100+ countries. Revenue is generated through Research & Development Solutions (CRO), Technology & Analytics Solutions (healthcare data), and Contract Sales & Medical Solutions. The company holds 1.2+ billion non-identified patient records.

Related stocks: SHC (Sotera Health Company) · GH (Guardant Health, Inc.) · MEDP (Medpace Holdings, Inc.) · ILMN (Illumina, Inc.) · BLLN (BillionToOne, Inc.)